Verified stock metrics
Regeneron Pharmaceuticals, Inc. Key Stock Metrics
Regeneron Pharmaceuticals, Inc. (REGN) market cap, valuation, profitability and…
Direct answer
Regeneron Pharmaceuticals, Inc. has 9 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 14, 2026.
Get free Regeneron Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $82.98B
- P/E ratio
- 19.76x
- Price-to-book ratio
- 2.55x
- Return on equity
- 14.04%
- Dividend yield
- 0.47%
- 52-week price range
- $541.00 to $821.11
- Revenue growth
- 16.7%
- Profit margin
- 27.87%
- Debt-to-equity ratio
- 8.54%
Explore related company data
View Regeneron Pharmaceuticals, Inc.'s market capitalizationView Regeneron Pharmaceuticals, Inc.'s p/e ratioView Regeneron Pharmaceuticals, Inc.'s price-to-book ratioView Regeneron Pharmaceuticals, Inc.'s return on equityView Regeneron Pharmaceuticals, Inc.'s dividend yieldView Regeneron Pharmaceuticals, Inc.'s 52-week price rangeView Regeneron Pharmaceuticals, Inc.'s revenue growthView Regeneron Pharmaceuticals, Inc.'s profit marginView Regeneron Pharmaceuticals, Inc.'s debt-to-equity ratioReturn to Regeneron Pharmaceuticals, Inc. profile